Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy |
Fred Hutchinson Cancer Research Center / Colin Godwin, MD |
Young Investigator Grants |
2018 |
Washington |
Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions |
Dana-Farber Cancer Institute / Cecile Rouleau, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors |
University of Florida / Chen Ling |
Young Investigator Grants |
2012 |
Florida |
The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia |
Children’s Hospital & Research Center at Oakland / Cheryl Peretz, MD |
Young Investigator Grants |
2019 |
California |
An Exploration of the Medulloblastoma and Glioblastoma Genomes: A Critical Analysis of Candidate Cancer Genes as Potential Molecular Targets for Diagnostics and Therapeutics
|
The Johns Hopkins University School of Medicine / Will Parsons, MD, PhD |
Young Investigator Grants |
2007 |
Maryland |
The Role of Metabolism in MLL-AF9 Leukemia Initiation |
Massachusetts General Hospital / Rushdia Yusuf |
Young Investigator Grants |
2010 |
Massachusetts |
Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.
|
Massachusetts General Hospital / David Langenau |
Young Investigator Grants |
2009 |
Massachusetts |
Beyond Febrile Neutropenia: Risks Associated with Antibiotic Choice in Children with Leukemia that Undergo Transplant |
Children’s Hospital of Philadelphia / Caitlin Elgarten, MD |
Young Investigator Grants |
2018 |
Pennsylvania |
Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma |
Boston Children’s Hospital / Shuibin Lin, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Engineering A Graft Versus Leukemia Effect into Cord Blood Transplant for Acute Lymphoblastic Leukemia |
Fred Hutchinson Cancer Research Center / Rebecca Gardner |
Young Investigator Grants |
2011 |
Washington |